<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04096339</url>
  </required_header>
  <id_info>
    <org_study_id>BIO-2018-0629</org_study_id>
    <nct_id>NCT04096339</nct_id>
  </id_info>
  <brief_title>Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First</brief_title>
  <acronym>RECoVER</acronym>
  <official_title>RECoVER: Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to compare the effect of different procedural sequences on&#xD;
      the time to recovery and the propofol sedation requirements in patients undergoing&#xD;
      bidirectional endoscopy with sedation.&#xD;
&#xD;
      The two sequences are:&#xD;
&#xD;
        -  Colonoscopy followed by Esophagogastroduodenoscopy (EGD)&#xD;
&#xD;
        -  EGD followed by Colonoscopy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      120 patients will be asked to participate in the trial. The subject will undergo both&#xD;
      procedures in the order assigned by the randomization sheet. During the procedure, the&#xD;
      endoscopist and anesthesiologists will collect data including but not limited to vital signs&#xD;
      (heart rate, blood oxygen level, blood pressure) and level of sedation through the Bispectral&#xD;
      Index Monitor (BIS). After completing the procedures, the patient will be approached in the&#xD;
      recovery room by the study coordinator who will administer the Modified Post Anesthesia&#xD;
      Discharge Scoring System (M-PADSS) scale every 5 minutes until a score of 9 or higher is&#xD;
      obtained on two consecutive attempts. 24 hours following the procedure, the study coordinator&#xD;
      will call the patient in order to assess the patient's cognitive function and drowsiness&#xD;
      after they were discharged from the endoscopy unit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 3, 2019</start_date>
  <completion_date type="Anticipated">January 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to discharge</measure>
    <time_frame>1 hour</time_frame>
    <description>Time from end of procedures to patient discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol dose</measure>
    <time_frame>1 hour</time_frame>
    <description>Propofol sedation requirements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depth of anesthesia</measure>
    <time_frame>1 hour</time_frame>
    <description>Bispectral Index (BIS) tracking of depth of anesthesia throughout the two procedures. BIS is a single dimensionless number generated by EEG analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive impairment</measure>
    <time_frame>24 hours</time_frame>
    <description>An assessment of cognitive impairment after the subject emerges from sedation, using the Modified Post Anesthesia Discharge System (M-PADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events during sedation</measure>
    <time_frame>1 hour</time_frame>
    <description>apnea, desaturations, hypotension, bradycardia and other hemodynamical disturbances during sedation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anesthesia, Recovery</condition>
  <arm_group>
    <arm_group_label>EGD followed by Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized to group Esophagogastroduodenoscopy followed by Colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colonoscopy followed by EGD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized to group Colonoscopy followed by Esophagogastroduodenoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Colonoscopy followed by EGD</intervention_name>
    <description>Colonoscopy is done first followed by EGD</description>
    <arm_group_label>Colonoscopy followed by EGD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EGD followed by Colonoscopy</intervention_name>
    <description>Esophagoduodenoscopy (EGD) is done first followed by Colonoscopy</description>
    <arm_group_label>EGD followed by Colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age above 18&#xD;
&#xD;
          -  Scheduled EGD and colonoscopy on the same day&#xD;
&#xD;
          -  Scheduled to Anaesthesiologist administered sedation during the procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age below 18&#xD;
&#xD;
          -  Known allergy or adverse reaction to Propofol, Midazolam or opioid medication (ex:&#xD;
             fentanyl)&#xD;
&#xD;
          -  Medical contraindication to Anaesthesia&#xD;
&#xD;
          -  Sleep apnea&#xD;
&#xD;
          -  American Society of Anesthesiologists classification (ASA) &gt;3&#xD;
&#xD;
          -  Inpatient status&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Known cirrhosis&#xD;
&#xD;
          -  Chronic Kidney Disease (stage 4 or 5)&#xD;
&#xD;
          -  Known psychological disorder&#xD;
&#xD;
          -  Known cognitive dysfunction&#xD;
&#xD;
          -  Significant gastroparesis&#xD;
&#xD;
          -  Gastric outlet obstruction&#xD;
&#xD;
          -  Ileus&#xD;
&#xD;
          -  Known or suspected bowel obstruction or perforation&#xD;
&#xD;
          -  Having a stoma&#xD;
&#xD;
          -  Compromised swallowing reflex or mental status&#xD;
&#xD;
          -  Prior colon resection or gastric surgery&#xD;
&#xD;
          -  Age above 75 years&#xD;
&#xD;
          -  Chronic use of more than 1 psychoactive drug (Benzodiazepines, Tricyclic&#xD;
             antidepressants, antipsychotics, selective serotonin receptor inhibitors, serotonin&#xD;
             norepinephrine receptor inhibitors, Monoamine oxidase inhibitor)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ala I Sharara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American University of Beirut Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ala I Sharara, MD</last_name>
    <phone>+961-1-350000</phone>
    <phone_ext>5345</phone_ext>
    <email>as08@aub.edu.lb</email>
  </overall_contact>
  <location>
    <facility>
      <name>American University of Beirut - Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ala' I. Sharara, MD</last_name>
      <phone>009611350000</phone>
      <phone_ext>5345</phone_ext>
      <email>as08@aub.edu.lb</email>
    </contact>
    <investigator>
      <last_name>Ala' I Sharara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 11, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>American University of Beirut Medical Center</investigator_affiliation>
    <investigator_full_name>Ala'a Sharara, MD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>EGD</keyword>
  <keyword>Sedation</keyword>
  <keyword>procedural sequence</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

